abstract |
A liquid, oral pharmaceutical composition is supplied. The composition comprises phenylephrine and polyethylene glycol substantially free of aldehyde. The composition has phenylephrine stably compatible with the required stability for commercial preparations. Optionally, the composition may comprise one or more additional active agents. |